×

BMJ – Evusheld: Government is urged to expedite covid antibody treatment for vulnerable patients

October 2022

Pink Sheet – Evusheld: UK urged to use RWD to give clinically vulnerable early access to COVID-19 treatment

September 2022

European Pharmaceutical Review – How can evidence-based medicine (EBM) methodology support drug withdrawals

July 2022

Pharmafocus – Key trends for UK drug safety in 2022

January 2022

News Medical – Heart inflammation more common among men following mRNA-based COVID-19 vaccination

September 2021

EPM magazine – The MedTalk Podcast – Understanding Covid-19 vaccines with the DSRU

August 2021

EPM magazine – Flu vaccine monitoring in the UK to include teenagers for the first time

August 2021

Pharma Jobs – DSRU says more research needed to understand immunocompromised patients’ responses to Covid-19 vaccines

July 2021

Pharmatimes – DSRU says more research needed to understand immunocompromised patients’ responses to Covid-19 vaccines

July 2021

Pink Sheet: Vaccine study kicks off in the UK (2/7/21 Covid notebook – subscription required)

July 2021

Guardian: Windmills of your mind: viral Covid jab ‘hack’ placebo effect at best, say doctors

June 2021

PharmaTimes – Safety first

May 2021

Guardian – Keep taking AstraZeneca jab, says PM, as trial paused to investigate clot reports (7/4/21 p6/7)

April 2021

Pharmacy Business – Pharmacists urged to promote Oxford vaccine safety study among patients

April 2021

European Pharmaceutical Review – Global pharmacovigilance observatory to aid pharma’s understanding of regulatory decisions

April 2021

PharmaTimes – Benefits of AZ vaccine outweigh risks, say MHRA

April 2021

Guardian – AstraZeneca jab worry may play into the hands of anti-vaxxers, say Tories Also covered by Yahoo and MSN

April 2021

Guardian – Wednesday briefing: Keep getting jab, Johnson urges

April 2021

MSN – Oxford/AstraZeneca jab could have causal link to rare blood clots, say UK experts

April 2021

Guardian – Oxford/AstraZeneca jab could have causal link to rare blood clots, say UK experts

April 2021

FT – Blood clots and the AstraZeneca Covid vaccine:

April 2021

Pharmacy Business – Pharmacists urged to promote Oxford vaccine safety study among patients

April 2021

Scrip – Regulators reassure on AZ vaccine safety after rare side effects deemed plausible

April 2021

Financial Review – European, UK experts turn up pressure on AstraZeneca over blood clots

April 2021

Nature – Covid vaccines and blood clots: Five key questions

April 2021

European Pharmaceutical Review – US pauses administration of Janssen Covid-19 vaccine

April 2021

Daily Mail – Why are drugs for the old tested on the young?

March 2021

The BMJ – Covid-19: Schedule breast screening before vaccine or 4 to 6 weeks after to avoid false positives, says guidance

March 2021

https://www.dailymail.co.uk/health/article-9339743/Why-drugs-old-tested-young.html

March 2021

European Pharmaceutical Manufacturer – Oxford/AstraZeneca Covid-19 vaccine should continue to be used, UK researchers say

March 2021

Pharmacy Business – Pharmacists urged to participate in Oxford vaccine safety study

March 2021

Guardian – Politics Live blog updating on a range of Covid-19 developments

March 2021

European Pharmaceutical Manufacturer – Post market study of Oxford Covid-19 vaccine begins

February 2021

Portsmouth News – Portsmouth associate drug safety unit to study side effects of COVID-19 vaccine

February 2021

South Wales Argus – Oxford/AstraZeneca vaccine safety study – Wales recruits needed

February 2021

Southampton Echo – Southampton drug safety unit to start study of COVID-19 vaccine

February 2021

Nursing Times – Call for nurses to join Covid-19 vaccine side effects study

February 2021

Reuters UK – What you need to know about coronavirus right now

December 2020

Newsbreak.com – New vaccine will be monitored long term to ‘build body of knowledge’

December 2020

County Press (Isle of Wight) – New vaccine will be monitored long term to ‘build body of knowledge’

December 2020

The National (Scotland) – New vaccine will be monitored long term to ‘build body of knowledge’

December 2020

Thisislocallondon – New vaccine will be monitored long term to ‘build body of knowledge’

December 2020

AOL – New vaccine will be monitored long term to ‘build body of knowledge’

December 2020

MSN – New vaccine will be monitored long term to ‘build body of knowledge’

December 2020

PharmaTimes – DSRU plans post-authorisation study of Covid-19 vaccines in the UK

December 2020

PharmaTimes – The Covid vaccines safety net

December 2020

European Pharmaceutical Manufacturer – UK research unit stresses need for monitoring of newly licensed Covid-19 vaccines

November 2020

Pink Sheet (16/11/20) – EU mandates monthly safety summaries for approved Covid-19 vaccines (DSRU comments on the need for robust post-authorisation safety studies)

November 2020

Pharmafocus – Opportunities and challenges for re-purposing drugs for Covid-19 (p12, Nov edition)

November 2020

European Pharmaceutical Review – Drug Safety Research Unit says repurposed drugs for Covid-19 still require a lot of testing

November 2020

European Pharmaceutical Manufacturer – Re-purposed drugs for Covid-19 need rigorous testing

November 2020

Pink Sheet (30/11/20) – Coronavirus Notepad: Repurposed drugs need thorough testing (link for subscribers)

November 2020

Pharmafile – Remdesivir has favourable benefit-risk profile in Covid-19 but more data needed, DSRU review argues

October 2020

Pharmatimes.co.uk – Systematic benefit-risk study deems remdesivir a favourable Covid-19 treatment

October 2020

Pink Sheet – Coronavirus Notebook: Convalescent Plasma – Will It Recover From Setbacks?

September 2020

The Scientist – Scientists voice concerns over Russian COVID-19 vaccine

September 2020

Chemistry World – Russian Covid-19 vaccine data raises questions

September 2020

BMJ – Covid-19: US FDA fires spokesperson over misleading claims about convalescent plasma. Summary of DSRU’s benefit risk research included.

September 2020

Pink Sheet – Coronavirus Notebook: Convalescent Plasma – Will It Recover From Setbacks?

August 2020

BMJ – Covid-19: US FDA fires spokesperson over misleading claims about convalescent plasma. Summary of DSRU’s benefit risk research included.

August 2020

Pink Sheet: Coronavirus Notebook – Post Authorization Studies. DSRU’s ‘One Million’ study to monitor COVID-19 vaccines was mentioned in Pink Sheet’s weekly round-up(18/8/20)

August 2020

European Pharmaceutical Review – COVID-19 vaccines to be monitored post marketing by consortium in the UK

August 2020

European Pharmaceutical Manufacturer – Post-market study to monitor safety and effectiveness of COVID-19 vaccines

August 2020

Pharmafield – One Million study to monitor COVID-19 vaccine safety and effectiveness

August 2020

Pharmafield – No clear benefit of HIV antivirals for COVID-19 patients says study

July 2020

Pink Sheet – Coronavirus Notebook

July 2020

European Pharmaceutical Review – Consortium established to monitor COVID-19 vaccines after marketing

June 2020

PharmaTimes – New consortium will monitor safety/efficacy of COVID-19 vaccines

June 2020

The Courier – Dundee and St Andrews universities spearheading Covid-19 vaccine studies

June 2020

Pharmaceutical Technology – UK researchers form consortium to monitor Covid-19 vaccines

June 2020

European Pharmaceutical Manufacturer – Consortium formed to assess safety of Covid-19 vaccines

June 2020

Pharmafield – New consortium to monitor safety and effectiveness of Covid-19 vaccines

June 2020

Pharmafile – New UK consortium established to monitor COVID-19 vaccine efficacy once they hit market

June 2020

Pink Sheet – New Consortium To Monitor Whether COVID-19 Vaccines Work As They Should

June 2020

PharmaTimes – PharmaTimes talks to Professor Saad Shakir

May 2020

PharmaTimes – Remdesivir for COVID-19 patients is ‘favourable’, study finds

May 2020

Pharmafile Therapeutic Areas in Focus – Direct oral anticoagulants: Examining their use in a real world secondary care setting (Vol 69 Spring 2020, p32-34)

May 2020

European Pharmaceutical Review – Cytokine storms a major killer in patients with severe COVID-19 infection

April 2020

Drug Target Review – Cytokine storms a major killer in patients with severe COVID-19 infection

April 2020

Pharmaceutical Journal – Buprenorphine implant beneficial for patients with opioid dependency

April 2020

PharmaTimes – BMJ journal deems opioid dependency implant more favourable than tablets

March 2020

Pharmafocus – The need for evolution in pharmacovigilance (p16/17 March 2020 edition)

March 2020

PharmaTimes – Improve brand and batch number recording, urge drug safety professionals

January 2020

Pharmafield – Better recording of biologic medicines brand and batch numbers needed for patient safety

January 2020

European Pharmaceutical Magazine – Improvements needed in biologics traceability to ensure patient safety

January 2020

Pharmaceutical Journal – Researchers unable to identify batches of biologic drugs from 85% of Yellow Card report

January 2020

PharmaTimes – Is the UK facing its own opioid crisis?

November 2019

The BMJ – GPs are urged to help monitor new drugs

October 2019

Daily Mail – ‘Last resort’ pill that brings nightmares (p.5 August print edition)

August 2019

LBC Radio – DSRU Director, Saad Shakir, interviewed for LBC Radio about the adverse side effects of anti-malaria drug, Mefloquine, in relation to the death of student Alana Cutland

August 2019

European Pharmaceutical Manufacturer Magazine – Use of real world data important for improving medicine safety

July 2019

OnMedica – Treatment for hyperthyroidism linked to increased risk of cancer death

July 2019

Daily Mail – Taking heartburn pills ‘DOUBLES your risk of developing an allergy because suppressing stomach acid destroys the body’s defense barrier’

July 2019

Pharma Times – Big Pharma, come back to mental health and invest in Europe

May 2019

Pharma Times – Big Pharma come together for better drug side effect detection

April 2019

Pink Sheet – New international signal detection initiative to influence industry practice

April 2019

Pharmaceutical Journal – Pharmaceutical companies vow to improve monitoring of medicine side effects

April 2019